Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Yuba City › NPI 1144733403
Physician

Vitreo-Retinal Medical Group INC

Vitreo-Retinal Medical Group INC was paid $505K by Medicaid between Oct 2018 and Oct 2024, across 11 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 46% of everything it billed.

33Billing provider infoVITREO-RETINAL MEDICAL GROUP INC
YUBA CITY, CA 95993
33aNPI1144733403assigned 11/08/2017
28Total paid$505K
24GClaims7,437
24DCodes billed11
24AFirst – last monthOct 2018 – Oct 2024
Compared with peers

Next to other Retina Specialist (Ophthalmology) Physician providers in California

Rank by total paid#14 of 45
Median peer was paid$55K
This provider vs. median9.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official PEARLMAN, JOEL controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201855$3K
2019306$8K
2020969$12K
20212,164$77K
20221,285$115K
20231,626$277K
2024incomplete1,032$12K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
J0178 Injection, aflibercept, 1 mg 46% 320 317 $234K
67028 Intravitreal injection of a pharmacologic agent 43% 2,518 2,248 $215K
92134 7.8% 3,694 3,615 $39K
J2778 Injection, ranibizumab, 0.1 mg 1.2% 55 52 $6K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity <1% 143 139 $4K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity <1% 208 208 $3K
J9035 Injection, bevacizumab, 10 mg <1% 40 39 $2K
92250 <1% 191 190 $1K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 203 197 $682.90
92235 <1% 53 53 $255.69
J7999 Compounded drug, not otherwise classified 0% 12 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPEARLMAN, JOEL (PRESIDENT)
Parent organizationVITREO-RETINAL MEDICAL GROUP, INC
Same official

Other billing entities under PEARLMAN, JOEL

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.